CliffBio

Shilpa Medicare

Patent cliffs & loss of exclusivity

Company

Seedtable URLhttps://seedtable.com/investors/shilpa-medicare
Official Websitehttps://vbshilpa.com/

6 upcoming patent cliffs

DrugIngredientTypeCliff
  1. DOCETAXELDOCETAXELSmall mol.Sep 2033
  2. DOCETAXELDOCETAXELSmall mol.Sep 2033
  3. DOCETAXELDOCETAXELSmall mol.Sep 2033
  4. PEMETREXEDPEMETREXED DISODIUMSmall mol.Mar 2035
  5. PEMETREXEDPEMETREXED DISODIUMSmall mol.Mar 2035
  6. PEMETREXEDPEMETREXED DISODIUMSmall mol.Mar 2035
  7. BUSULFANBUSULFANSmall mol.—
  8. DOCETAXELDOCETAXELSmall mol.—
  9. DOCETAXELDOCETAXELSmall mol.—
  10. DOCETAXELDOCETAXELSmall mol.—
  11. GEMCITABINE HYDROCHLORIDEGEMCITABINE HYDROCHLORIDESmall mol.—
  12. GEMCITABINE HYDROCHLORIDEGEMCITABINE HYDROCHLORIDESmall mol.—
  13. GEMCITABINE HYDROCHLORIDEGEMCITABINE HYDROCHLORIDESmall mol.—
  14. GEMCITABINE HYDROCHLORIDEGEMCITABINE HYDROCHLORIDESmall mol.—
  15. GEMCITABINE HYDROCHLORIDEGEMCITABINE HYDROCHLORIDESmall mol.—
  16. IRINOTECAN HYDROCHLORIDEIRINOTECAN HYDROCHLORIDESmall mol.—
  17. IRINOTECAN HYDROCHLORIDEIRINOTECAN HYDROCHLORIDESmall mol.—
  18. IRINOTECAN HYDROCHLORIDEIRINOTECAN HYDROCHLORIDESmall mol.—
  19. ZOLEDRONIC ACIDZOLEDRONIC ACIDSmall mol.—
  20. AZACITIDINEAZACITIDINESmall mol.—
  21. BORTEZOMIBBORTEZOMIBSmall mol.—
  22. APREMILASTAPREMILASTSmall mol.—
  23. APREMILASTAPREMILASTSmall mol.—
  24. APREMILASTAPREMILASTSmall mol.—
  25. CAPECITABINECAPECITABINESmall mol.—
  26. CAPECITABINECAPECITABINESmall mol.—
  27. ERLOTINIB HYDROCHLORIDEERLOTINIB HYDROCHLORIDESmall mol.—
  28. ERLOTINIB HYDROCHLORIDEERLOTINIB HYDROCHLORIDESmall mol.—
  29. ERLOTINIB HYDROCHLORIDEERLOTINIB HYDROCHLORIDESmall mol.—
  30. IMATINIB MESYLATEIMATINIB MESYLATESmall mol.—
  31. IMATINIB MESYLATEIMATINIB MESYLATESmall mol.—
  32. VARENICLINE TARTRATEVARENICLINE TARTRATESmall mol.—
  33. VARENICLINE TARTRATEVARENICLINE TARTRATESmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.